HSF1 modulates lipid metabolism and ferroptosis in sarcopenia: a novel diagnostic biomarker and therapeutic target
Open Access
- 30 April 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 13, 1727633
Abstract
Background: Sarcopenia, an age-correlated decline in skeletal muscle mass and function, has been increasingly linked to ferroptosis, which is an iron-dependent form of regulated cell death driven by lipid peroxidation. Nevertheless, the diagnostic potential and mechanistic role of ferroptosis-relevant genes (FRGs) in sarcopenia remains poorly understood. Methods: We integrated bioinformatics analyses and experimental validation to identify and characterize key FRGs in sarcopenia. By employing RNA-seq data from public datasets (GSE25941 and GSE9103), we identified differentially expressed FRGs and applied weighted gene co-expression network analysis (WGCNA) and multiple machine learning algorithms (comprising LASSO, SVM, KNN, XGBoost, and NNET) to screen for diagnostic biomarkers. Results: Six hub FRGs ( ACSL6 , CDKN1A , ATG4D , DECR1 , HSF1 , and MIB1 ) were identified with AUC>0.8 as robust diagnostic biomarkers, among which HSF1 exhibited the highest diagnostic value (AUC = 0.9247). Molecular docking suggested quercetin and cycloheximide as potential therapeutic agents targeting HSF1. As demonstrated by functional experiments in C2C12 myoblasts, HSF1 silencing facilitated lipid metabolism, elevated ferroptosis markers, and induced muscle atrophy, while its overexpression attenuated these effects. Conclusion: Our findings not only underscore the significance of FRGs in sarcopenia pathogenesis but also highlight their potential as diagnostic markers and therapeutic targets.Keywords
This publication has 62 references indexed in Scilit:
- Skeletal Muscle HSF1 Alleviates Age‐Associated Sarcopenia and Mitochondrial Function Decline via SIRT3‐PGC1α AxisAdvanced Science, 2025
- Therapeutic Targeting of Decr1 Ameliorates Cardiomyopathy by Suppressing Mitochondrial Fatty Acid Oxidation in Diabetic MiceJournal of Cachexia, Sarcopenia and Muscle, 2025
- FOXO regulation of TXNIP induces ferroptosis in satellite cells by inhibiting glutathione metabolism, promoting SarcopeniaCellular and Molecular Life Sciences, 2025
- SRSF1 Is Crucial for Maintaining Satellite Cell Homeostasis During Skeletal Muscle Growth and RegenerationJournal of Cachexia, Sarcopenia and Muscle, 2024
- Novel metabolic and lipidomic biomarkers of sarcopeniaJournal of Cachexia, Sarcopenia and Muscle, 2024
- Serum HSF1 is upregulated in endometriosis patients and serves as a potential diagnostic biomarkerThe Kaohsiung Journal of Medical Sciences, 2023
- Exercise for sarcopenia in older people: A systematic review and network meta‐analysisJournal of Cachexia, Sarcopenia and Muscle, 2023
- Resistance exercise and nutritional interventions for augmenting sarcopenia outcomes in chronic kidney disease: a narrative reviewJournal of Cachexia, Sarcopenia and Muscle, 2021
- Transferrin receptor 1 ablation in satellite cells impedes skeletal muscle regeneration through activation of ferroptosisJournal of Cachexia, Sarcopenia and Muscle, 2021
- Construction of a lipid metabolism‐related and immune‐associated prognostic signature for hepatocellular carcinomaCancer Medicine, 2020